Le Lézard
Classified in: Health, Covid-19 virus
Subject: ACC

AltaPointe works to ensure access to care during COVID-19


MOBILE, Ala., July 8, 2020 /PRNewswire-PRWeb/ -- The Federal Communications Commission's Wireline Competition Bureau today approved an additional 25 funding applications for the COVID-19 Telehealth Program, and AltaPointe Health is among the recipients. Health care providers in both urban and rural areas of the country will use the funding to provide telehealth services during the coronavirus pandemic. Since the beginning of the FCC's COVID-19 Telehealth Program, the agency has approved 539 funding applications in 47 states plus Washington, D.C. and Guam for a total of $200 million in funding?the amount of money provided by Congress in the CARES Act.

"In late March, Congress tasked the FCC with developing from scratch a new $200 million COVID-19 Telehealth Program to help combat COVID-19, support health care providers, and make it easier for Americans to safely access vital healthcare services," said FCC Chairman Ajit Pai. "And just over three months later, the Commission has approved 539 applications, allocating the full $200 million for worthy projects across the country."

Telehealth is an effective and innovative way to deliver quality healthcare services. Even before the COVID-19 outbreak, is was evident that the popularity of virtual care is rising and will only continue its upward trend. AltaPointe clinicians provided 13,133 telehealth services across seven counties in Alabama in 22019.

Telehealth removes barriers to care, allowing providers to virtually see patients anytime, anywhere through the use of mobile technologies. AltaPointe's philosophy is to be the best IT-driven health and human services organization.

To read the full press release

 

SOURCE AltaPointe Health


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: